Cognitive-behavioral therapy and buprenorphine for opioid use disorder: A systematic review and meta-analysis of randomized controlled trials

References

• National Institute on Drug Abuse. Opioid overdose crisis. [accessed 2020 Jan 29]. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis.
   Google Scholar
• Centers for Disease Control and Prevention. Drug overdose deaths. [accessed 2020 Jan 29]. https://www.cdc.gov/drugoverdose/data/statedeaths.html.
   Google Scholar
• Chen Q, Larochelle MR, Weaver DT, Lietz AP, Mueller PP, Mercaldo S, Wakeman SE, Freedberg KA, Raphel TJ, Knudsen AB, et al. Prevention of prescription opioid misuse and projected overdose deaths in the United States. JAMA Netw Open. 2019;2:e187621.
   PubMed Web of Science ®Google Scholar
• Svendsen K, Fredheim OM, Romundstad P, Borchgrevink PC, Skurtveit S. Persistent opioid use and socio-economic factors: a population-based study in Norway. Acta Anaesthesiol Scand. 2014 February;58:437–45. doi:https://doi.org/10.1111/aas.12281.
   PubMed Web of Science ®Google Scholar
• Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor R, Fry-Smith A, Day E, Lintzeris N, Roberts T, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11:1.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies: tackling the opioid-overdose epidemic. NEJM. 2014;370:2063–66. doi:https://doi.org/10.1056/NEJMp1402780.
   PubMed Web of Science ®Google Scholar
• Haffajee RL, Bohnert ASB, Lagisetty PA. Policy pathways to address provider workforce barriers to buprenorphine treatment. Am J Prev Med. 2018;54:S230–S242. doi:https://doi.org/10.1016/j.amepre.2017.12.022.
   PubMed Web of Science ®Google Scholar
• Ma J, Bao Y-P, Wang R-J, Su M-F, Liu M-X, Li J-Q, Degenhardt L, Farrell M, Blow FC, Ilgen M, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;24:1868–83.
   PubMed Web of Science ®Google Scholar
• Tinkler E, Vallejos Bartlett C, Brooks M, Gilbert JM, Henderson R, Shuman DJ. Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol (TIP) Series 43. Substance abuse and mental health services administration; 2005 January.
   Google Scholar
• Center for Substance Abuse Treatment. Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment improvement protocol (TIP) Series 40. Substance abuse and mental health services administration. ; 2004 January.
   Google Scholar
• Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: A meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70:516–27. doi:https://doi.org/10.15288/jsad.2009.70.516.
   PubMed Web of Science ®Google Scholar
• Dobson KS. Cognitive therapy. Washington, DC: American Psychological Association; 2012.
   Google Scholar
• Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: the process and practice of mindful change. 2nd ed. New York (NY): Guilford Press; 2012. p. 50.
   Google Scholar
• Mueser KT, Noordsy DL, Drake RE, Fox L. Integrated treatment for dual disorders: A guide to effective practice. New York (NY): Guilford Press; 2003.
   Google Scholar
• Hofmann S, Asnaani A, Vonk I, Sawyer A, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Ther Res. 2012;36:427–40. doi:https://doi.org/10.1007/s10608-012-9476-1.
   PubMed Web of Science ®Google Scholar
• Hayes SC. Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies-republished article. Behav Ther. 2016;47:869–85. doi:https://doi.org/10.1016/j.beth.2016.11.006.
   PubMed Web of Science ®Google Scholar
• Beck AT, Wright FD, Newman CF, Liese BS. Cognitive therapy of substance abuse. New York (NY): Guilford Press; 1993.
   Google Scholar
• Marlatt GA, Gordon JR, Eds. Relapse prevention. Marlatt GA, Gordon JR. Relapse prevention: Maintenance Strategies in the Treatment of Addictive Behaviors, 2nd Ed. (Marlatt GA, Donovan DM, eds.). New York (NY): The Guilford New York (NY): Guilford Press; 1985.
   Google Scholar
• Marlatt GA, Donovan DM. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. 2nd ed. Marlatt GA, Donovan DM, eds. New York (NY): The Guilford; 2005.
   Google Scholar
• Wenzel A, Liese BS, Beck AT, Friedman-Wheeler DG. Group cognitive therapy for addictions. New York, (NY): Guilford Press; 2012.
   Google Scholar
• Hendy HM, Black P, Can SH, Fleischut A, Aksen D. Opioid abuse as maladaptive coping to life stressors in U.S. adults. J Drug Issues. 2018;48:560–71. doi:https://doi.org/10.1177/0022042618783454.
   Web of Science ®Google Scholar
• Brown AR. A systematic review of psychosocial interventions in treatment of opioid addiction. J Soc Work Pract Addict. 2018;18:249–69. doi:https://doi.org/10.1080/1533256X.2018.1485574.
   Web of Science ®Google Scholar
• Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10:93–103. doi:https://doi.org/10.1097/ADM.0000000000000193.
   PubMed Web of Science ®Google Scholar
• Sokol R, LaVertu AE, Morrill D, Albanese C, Schuman-Olivier Z. Group-based treatment of opioid use disorder with buprenorphine: A systematic review. J Subst Abuse Treat. 2018;84:78–87. doi:https://doi.org/10.1016/j.jsat.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev. 2011;CD004147. doi:https://doi.org/10.1002/14651858.CD004147.pub4.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester (UK): John Wiley & Sons; 2009.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:1–6. doi:https://doi.org/10.1371/journal.pmed.1000097.
   Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM – 5. 5th ed. Washington, DC: American Psychiatric Association; 2013.
   Google Scholar
• Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook of systematic reviews of interventions. Chichester (UK): John Wiley & Sons; 2008. p. 187–241.
   Google Scholar
• Biostat. Comprehensive meta-analysis (Version 3) [software]. Englewood (NJ/USA): Biostat; 2020.
   Google Scholar
• Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Erlbaum; 1988.
   Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327:557–60. doi:https://doi.org/10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Higgins JPT, Hedges LV, Rothstein HR. Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res Synth Methods. 2017;8:5–18. doi:https://doi.org/10.1002/jrsm.1230.
   PubMed Web of Science ®Google Scholar
• Nagashima K, Noma H, Furukawa TA. Prediction intervals for random-effects meta-analysis: A confidence distribution approach. Stat Methods Med Res. 2019;28:1689–702. doi:https://doi.org/10.1177/0962280218773520.
   PubMed Web of Science ®Google Scholar
• Fiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O’Connor PG, Schottenfeld RS. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Am J Med. 2013;126:74.e11-7.
   PubMed Web of Science ®Google Scholar
• Ling W, Hillhouse M, Ang A, Jenkins J, Fahey J. Comparison of behavioral treatment conditions in buprenorphine maintenance. Addiction. 2013;108:1788–98. doi:https://doi.org/10.1111/add.12266.
   PubMed Web of Science ®Google Scholar
• Miotto K, Hillhouse M, Donovick R, Cunningham-Rathner J, Charuvastra C, Torrington M, Esagoff AE, Ling W. Comparison of buprenorphine treatment for opioid dependence in 3 settings. J Addict Med. 2012;6:68–76.
   PubMed Web of Science ®Google Scholar
• Shi JM, Henry SP, Dwy SL, Orazietti SA, Carroll KM. Randomized pilot trial of web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance. Substance Abuse. 2019 February;40:132–35. doi:https://doi.org/10.1080/08897077.2019.1569192.
   PubMed Web of Science ®Google Scholar
• Brigham GS, Slesnick N, Winhusen TM, Lewis DF, Guo X, Somoza E. A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification. Drug Alcohol Depend. 2014;138:240–43. [Trial not being able to provide an estimates of a biological sample outcome]. doi:https://doi.org/10.1016/j.drugalcdep.2014.02.013.
   PubMed Web of Science ®Google Scholar
• Lander LR, Gurka KK, Marshalek PJ, Riffon M, Sullivan CR. A comparison of pregnancy-only versus mixed-gender group therapy among pregnant women with opioid use disorder. Soc Work Res. 2015;39:235–44. [Both arms of the trial received CBT or some psychosocial treatment considered CBT]. doi:https://doi.org/10.1093/swr/svv029.
   Web of Science ®Google Scholar
• Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH. A randomized trial of intensive outpatient (IOP) vs standard outpatient (OP) buprenorphine treatment for African Americans. Drug Alcohol Depend. 2013;128:222–29. [The study intervention was not described in such a way that it could reasonably be considered to have used CBT in accordance with the inclusion criteria]. doi:https://doi.org/10.1016/j.drugalcdep.2012.08.027.
   PubMed Web of Science ®Google Scholar
• Moore BA, Fiellin DA, Cutter CJ, Buono FD, Barry DT, Fiellin LE, O’Connor PG, Schottenfeld RS. Cognitive behavioral therapy improves treatment outcomes for prescription opioid users in primary care buprenorphine treatment. J Subst Abuse Treat. 2016;71:54–57. doi:https://doi.org/10.1016/j.jsat.2016.08.016. [Study having been reported elsewhere].
   PubMed Web of Science ®Google Scholar
• Raisch DW, Campbell HM, Garnand DA, Jones MA, Sather MR, Naik R, Ling W. Health-related quality of life changes associated with buprenorphine treatment for opioid dependence. Qual Life Res. 2012;21:1177–83. doi:https://doi.org/10.1007/s11136-011-0027-0. [Study having been reported elsewhere].
   PubMed Web of Science ®Google Scholar
• Watkins KE, Ober AJ, Lamp K, Lind M, Setodji C, Osilla KC, Hunter SB, McCullough CM, Becker K, Iyiewuare PO, et al. Collaborative care for opioid and alcohol use disorders in primary care: the SUMMIT randomized clinical trial. JAMA Intern Med. 2017;177:1480–88. doi:https://doi.org/10.1001/jamainternmed.2017.3947. [The control group did not receive buprenorphine].
   PubMed Web of Science ®Google Scholar
• Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998;352:609–13.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–12. doi:https://doi.org/10.1001/jama.273.5.408.
   PubMed Web of Science ®Google Scholar
• Woods JS, Joseph H. Stigma from the viewpoint of the patient. J Addict Dis. 2015;34:238–47. doi:https://doi.org/10.1080/10550887.2015.1059714.
   PubMed Web of Science ®Google Scholar
• Madden EF. Intervention stigma: how medication-assisted treatment marginalizes patients and providers. Soc Sci Med. 2019;232:324–31. doi:https://doi.org/10.1016/j.socscimed.2019.05.027.
   PubMed Web of Science ®Google Scholar
• Akdağ EM, Kotan VO, Kose S, Tıkır B, Aydemir MÇ, Okay İT, Göka E, Özkaya G. The relationship between internalized stigma and treatment motivation, perceived social support, depression and anxiety levels in opioid use disorder. Psychiat Clin Psych. 2018;28:394–401.
   Google Scholar
• Yalom ID. The theory and practice of group psychotherapy. 5th ed. New York (NY): Basic Books; 2008.
   Google Scholar
• Schure MB, Howard M, Bailey SJ, Bryan B, Greist J. Exploring perceptions of a computerized cognitive behavior therapy program in a US rural western state. J Rural Ment Health. 2018;42:174–83. doi:https://doi.org/10.1037/rmh0000102.
   Google Scholar
• Schwartz W. The social worker in the group. In: New perspectives on services to groups: theory, organization, practice. New York (NY): National Association of Social Workers; 1961. p. 7–34.
   Google Scholar
• Shulman L. The skills of helping individuals, families, groups, and communities. 4th ed. Itasca (Ill): Peacock Publishers; 1999.
   Google Scholar
• Jakubowski A, Fox A. Defining Low-threshold Buprenorphine Treatment. J Addict Med. 2020;14:95–98. doi:https://doi.org/10.1097/ADM.0000000000000555.
   PubMed Web of Science ®Google Scholar
• Card NA. Applied meta-analysis for social science research. New York (NY): Guilford Press; 2012.
   Google Scholar
• Substance Abuse and Mental Health Services Administratio. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63. Publication No. PEP20-02-01-006. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2020.
   Google Scholar
• Winograd RP, Presnall N, Stringfellow E, Wood C, Horn P, Duello A, Green L, Rudder T. The case for a medication first approach to the treatment of opioid use disorder. Am J Drug Alcohol Abuse. May 2019;45:333–40. doi:https://doi.org/10.1080/00952990.2019.1605372.
   PubMed Web of Science ®Google Scholar
• Beaudoin FL, Janicki A, Zhai W, Choo EK. Trends in opioid prescribing before and after implementation of an emergency department opioid prescribing policy. Am J Emerg Med. 2018;36:329–31. doi:https://doi.org/10.1016/j.ajem.2017.07.068.
   PubMed Web of Science ®Google Scholar
• Sallis JF, Owen N. Ecological models of health behavior. In: Glanz K, Rimer BK, Viswanath K editors, Health behavior: theory, research, and practice 5th. San Francisco (CA): John Wiley & Sons; 2015. p. 43–64.
   Google Scholar
• Prochaska JO, Redding CA, Evans KE. The transtheoretical model and stages of change. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior: theory, research, and practice. 5th ed. San Francisco (CA): John Wiley & Sons; 2015. p. 125–48.
   Google Scholar